Skip to content

Edgewise Therapeutics, Inc. EWTX Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
-$1.18M-107%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$2.45M+65.1%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$32.85M+757%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$4.63M-148%
Scholar Rock logo
Scholar RockSRRK
$2.04M-70.8%
Cytokinetics logo
CytokineticsCYTK

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%
Total assets$518.5M+14.1%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Market cap$4.18B+61.3%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0.0×
Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
Edgewise Therapeutics, Inc. (EWTX) reported increase (decrease) in prepaid expense and other assets of -$3.05M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Edgewise Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 306.0% year-over-year, from $1.48M to -$3.05M.
What is the long-term trend for Edgewise Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
Over 2 years (2023 to 2025), Edgewise Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a 49.7% compound annual growth rate (CAGR), from $3.55M to $7.96M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.